Article Listing - Sales for first four months disappoint at GW, expected to pick up in second

ARES-SERONO Rx DRUG SALES UP 15.5%

16 March 1992

On group sales of $751.1 million for the year ended December 31, 1991 (reported in brief last week), Swiss-based Ares-Serono...

MEDEVA'S ROAD TO SUCCESS

16 March 1992

Ahead of the company's 1991 financal results, which are due out next week, there has been a variety of comment...

US ORPHAN DRUG CHANGE "WOULD BE VETOED"

16 March 1992

The US Bush Administration is strongly opposed to S 2060, the Senate legislation which proposes to end the market monopoly...

FRENCH DOCTORS ATTACK COST DEAL

16 March 1992

The French general practitioners' union, MG-France, has warned of the effects which the health cost control deal just agreed between...

LIFEGrOUP CHANGES ACQUISITION PLAN

16 March 1992

After a long period of analysis and negotiation, Italy's LIFEGROUP, founded in 1991, has decided against proceeding with the planned...

PHARMA UNIT SALE LIFTS GIST-BROCADES

16 March 1992

Excluding the pharmaceuical division which it sold to Yamanouchi last year, Dutch company Gist-Brocades saw turnover for 1991 increase by...

BBG'S DETECTION KITS

16 March 1992

- British Bio-technology Prod-ucts Ltd has expanded its range of in situ hybridization products to include a Detection Module for...

TAMOXIFEN TRIAL IN MEN

16 March 1992

- Imperial Chemical Indus-tries' Nolvadex (tamoxifen) is prolonging the lives of men with breast cancer, according to results of a...

GENZYME AND GLYCOPROTEINS

16 March 1992

- Genzyme Corp, in collaboration with Robert Van Etten and colleagues at Purdue University, Indiana, has developed technol-ogy which could...

COMBO THERAPY FOR LEISHMANIASIS

16 March 1992

- The combination of allopurinol and meglumine antimoniate is more effective than the latter alone for American cutaneous leishmaniasis, according...

Showing 94611-94620 of 95356 articles

Go to beginningPreviousNextGo to end